Medicare confirms payment for prostate cancer drug – San Francisco Chronicle
|
Medicare confirms payment for prostate cancer drug
San Francisco Chronicle Medicare officials confirmed Thursday that the program will cover the $ 93000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the … Medicare to cover Dendreon's prostate drug Dendreon, After Yearlong Inquiry, Sways Medicare to Pay for $ 93000 Prostate … Medicare confirms payment for prostate cancer drug |
Short URL: http://trends-medical.com/?p=289
Posted by admin
on Jun 30 2011. Filed under DRUGS & SUPPLEMENTS.
You can follow any responses to this entry through the RSS 2.0.
Both comments and pings are currently closed.